| Product Code: ETC8541586 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, lentiviral vector import shipments to the Netherlands continued to show high concentration, with top exporting countries being Belgium, Hungary, USA, Japan, and Sweden. Despite a noticeable decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period of 2020-2024 remained positive at 3.85%. This data suggests a stable market for lentiviral vector imports, with key players maintaining their strong presence in the Netherlands market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Lentiviral Vector Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Lentiviral Vector Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Lentiviral Vector Market - Industry Life Cycle |
3.4 Netherlands Lentiviral Vector Market - Porter's Five Forces |
3.5 Netherlands Lentiviral Vector Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 Netherlands Lentiviral Vector Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Netherlands Lentiviral Vector Market Revenues & Volume Share, By Generation, 2021 & 2031F |
3.8 Netherlands Lentiviral Vector Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Netherlands Lentiviral Vector Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.10 Netherlands Lentiviral Vector Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.11 Netherlands Lentiviral Vector Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Netherlands Lentiviral Vector Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in gene therapy and cell therapy fields |
4.2.2 Rising prevalence of genetic disorders and chronic diseases driving the demand for lentiviral vectors |
4.2.3 Growing investments and funding in biotechnology and pharmaceutical sectors in the Netherlands |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and complexities associated with gene therapy products |
4.3.2 High cost of development and production of lentiviral vectors |
4.3.3 Limited awareness and adoption of gene therapy treatments in the market |
5 Netherlands Lentiviral Vector Market Trends |
6 Netherlands Lentiviral Vector Market, By Types |
6.1 Netherlands Lentiviral Vector Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Lentiviral Vector Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 Netherlands Lentiviral Vector Market Revenues & Volume, By Lentiviral Promoter, 2021- 2031F |
6.1.4 Netherlands Lentiviral Vector Market Revenues & Volume, By Lentiviral Fusion Tags, 2021- 2031F |
6.1.5 Netherlands Lentiviral Vector Market Revenues & Volume, By Lentiviral Packaging Systems, 2021- 2031F |
6.1.6 Netherlands Lentiviral Vector Market Revenues & Volume, By Other, 2021- 2031F |
6.2 Netherlands Lentiviral Vector Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Lentiviral Vector Market Revenues & Volume, By Product, 2021- 2031F |
6.2.3 Netherlands Lentiviral Vector Market Revenues & Volume, By Services, 2021- 2031F |
6.3 Netherlands Lentiviral Vector Market, By Generation |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Lentiviral Vector Market Revenues & Volume, By 4th-Generation, 2021- 2031F |
6.3.3 Netherlands Lentiviral Vector Market Revenues & Volume, By 3rd-Generation, 2021- 2031F |
6.3.4 Netherlands Lentiviral Vector Market Revenues & Volume, By 2nd-Generation, 2021- 2031F |
6.3.5 Netherlands Lentiviral Vector Market Revenues & Volume, By 1st-Generation, 2021- 2031F |
6.4 Netherlands Lentiviral Vector Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Lentiviral Vector Market Revenues & Volume, By Upstream Processing, 2021- 2031F |
6.4.3 Netherlands Lentiviral Vector Market Revenues & Volume, By Downstream Processing, 2021- 2031F |
6.5 Netherlands Lentiviral Vector Market, By Delivery Method |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Lentiviral Vector Market Revenues & Volume, By In Vivo, 2021- 2031F |
6.5.3 Netherlands Lentiviral Vector Market Revenues & Volume, By Ex Vivo, 2021- 2031F |
6.6 Netherlands Lentiviral Vector Market, By Disease Indication |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Lentiviral Vector Market Revenues & Volume, By Cancer, 2021- 2031F |
6.6.3 Netherlands Lentiviral Vector Market Revenues & Volume, By Genetic Disorders, 2021- 2031F |
6.6.4 Netherlands Lentiviral Vector Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.6.5 Netherlands Lentiviral Vector Market Revenues & Volume, By Veterinary Disease, 2021- 2031F |
6.6.6 Netherlands Lentiviral Vector Market Revenues & Volume, By Other, 2021- 2031F |
6.7 Netherlands Lentiviral Vector Market, By Application |
6.7.1 Overview and Analysis |
6.7.2 Netherlands Lentiviral Vector Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.7.3 Netherlands Lentiviral Vector Market Revenues & Volume, By Vaccinology, 2021- 2031F |
6.8 Netherlands Lentiviral Vector Market, By End User |
6.8.1 Overview and Analysis |
6.8.2 Netherlands Lentiviral Vector Market Revenues & Volume, By Biotechnology Companies, 2021- 2031F |
6.8.3 Netherlands Lentiviral Vector Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.8.4 Netherlands Lentiviral Vector Market Revenues & Volume, By Contract Development and Manufacturing Organization (CDMO), 2021- 2031F |
6.8.5 Netherlands Lentiviral Vector Market Revenues & Volume, By Contract Development and Manufacturing Organization (CDMO), 2021- 2031F |
6.8.6 Netherlands Lentiviral Vector Market Revenues & Volume, By Academic/ Research Institutes, 2021- 2031F |
7 Netherlands Lentiviral Vector Market Import-Export Trade Statistics |
7.1 Netherlands Lentiviral Vector Market Export to Major Countries |
7.2 Netherlands Lentiviral Vector Market Imports from Major Countries |
8 Netherlands Lentiviral Vector Market Key Performance Indicators |
8.1 Number of clinical trials utilizing lentiviral vectors in the Netherlands |
8.2 Research and development expenditure in gene therapy and cell therapy sectors |
8.3 Number of partnerships and collaborations between biotech companies and research institutions in the Netherlands |
9 Netherlands Lentiviral Vector Market - Opportunity Assessment |
9.1 Netherlands Lentiviral Vector Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 Netherlands Lentiviral Vector Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Netherlands Lentiviral Vector Market Opportunity Assessment, By Generation, 2021 & 2031F |
9.4 Netherlands Lentiviral Vector Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Netherlands Lentiviral Vector Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.6 Netherlands Lentiviral Vector Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.7 Netherlands Lentiviral Vector Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Netherlands Lentiviral Vector Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Netherlands Lentiviral Vector Market - Competitive Landscape |
10.1 Netherlands Lentiviral Vector Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Lentiviral Vector Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here